Autonomix Medical, Inc. (AMIX) News
Follow Autonomix Medical, Inc. (AMIX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 24 public stories across 14 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
H
Autonomix Medical Completes Pre-Submission Meeting With FDA For Its Transvascular Sensing Platform
Autonomix Medical, Inc. (NASDAQ: AMIX ) ("Autonomix" or the "Company"), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced the successful completion of a pre-submission m
LIVE | Sep 30, 2026, 12:32 PM UTC
L
Autonomix Medical, Inc. (AMIX) Gets FDA Feedback Supporting 510(k) Path
Autonomix said FDA pre-submission feedback supports a Class II substantial-equivalence 510(k) pathway for its standalone sensing platform, with potential U.S. clearance targeted in approximately 15 months, subject to dev
REGULATION | Sep 30, 2026, 12:32 PM UTC
L
Autonomix Reports Positive FDA Feedback Supporting 510(k) Pathway to U.S. Clearance
FDA pre-submission feedback supports a Class II strategy, leveraging substantial equivalence to a previously cleared device, positioning the Company for potential initial U.S. clearance of its standalone sensing platform
REGULATION | Sep 30, 2026, 12:31 PM UTC
L
Autonomix Medical Expands Global Intellectual Property Footprint with European Patent Supporting Precision Neuromodulation Platform
European patent strengthens protection for proprietary autonomic nervous system assessment technologies, further expanding Company's international patent portfolioTHE WOODLANDS, TX, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Aut
NEWS | Sep 24, 2026, 12:32 PM UTC
L
AMIX - Autonomix Medical Expands Global Intellectual Property Footprint with European Patent Supporting Precision Neuromodulation Platform
AMIX - Autonomix Medical Expands Global Intellectual Property Footprint with European Patent Supporting Precision Neuromodulation Platform
NEWS | Sep 24, 2026, 12:30 PM UTC
L
AMIX - Autonomix Medical Appoints Former Medtronic Chief Regulatory Counsel Sandra Cohen Kalter to Board of Directors
AMIX - Autonomix Medical Appoints Former Medtronic Chief Regulatory Counsel Sandra Cohen Kalter to Board of Directors
NEWS | Sep 16, 2026, 12:30 PM UTC
L
Autonomix Medical accepts two abstracts for CIRSE 2026 poster
Autonomix Medical announced acceptance of two abstracts for poster presentation at CIRSE 2026. The abstracts highlight potential of the company’s transvascular technology across pain management and nervous system mapping
EQUITY | Sep 01, 2026, 12:37 PM UTC
L
AMIX: Autonomix Medical accepts two CIRSE 2026 abstract posters
Autonomix Medical said two abstracts were accepted for poster presentation at CIRSE 2026.
EQUITY | Sep 01, 2026, 12:31 PM UTC
L
Autonomix Medical raises $4.9 million via warrant exercise
Autonomix Medical raised $4.9 million through a warrant exercise and issued new five-year warrants.
EQUITY | Aug 26, 2026, 09:04 PM UTC
L
Autonomix Medical expands IP portfolio with new U.S. patent
TradeXchange Newsdesk reports AMIX received a new U.S. patent covering feedback-guided precision neuromodulation and targeted therapy delivery.
EQUITY | Aug 26, 2026, 12:30 PM UTC
M
Small-cap premarket movers surge: AIXI, RCON, DAIC lead gains
Premarket small-cap winners include AIXI up +200%, RCON up +150%, and DAIC up +83% on contract, financing, and Nasdaq-related headlines, alongside multiple other large-percentage gainers.
EQUITY | Aug 25, 2026, 12:07 PM UTC
L
Autonomix Medical (AMIX) raises $4.9 million via warrant inducement
Autonomix Medical (AMIX) enters into a $4.9 million warrant inducement, priced at a premium to market under Nasdaq rules.
EQUITY | Aug 25, 2026, 01:06 AM UTC
M
AMIX Completes GLP Preclinical Study
AMIX completes Good Laboratory Practice preclinical study
EQUITY | Aug 12, 2026, 12:15 PM UTC
H
Why Arista Networks Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Shares of Arista Networks Inc (NYSE: ANET ) rose sharply in pre-market trading after the company reported better-than-expected second-quarter financial results and issued strong third-quarter guidance. Arista Networks re
EARNINGS | Aug 05, 2026, 08:57 AM UTC
H
Small Caps Surge
Several small caps see large gains
EQUITY | Aug 04, 2026, 01:13 PM UTC
H
Dow Tumbles 400 Points; Procter & Gamble Shares Fall After Q4 Results
U.S. stocks traded mostly lower this morning, with the Dow Jones index falling more than 400 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.78% to 52,334.00 while the NASDAQ declined 0
EARNINGS | Jul 29, 2026, 01:46 PM UTC
L
Multiple Companies File Forms
Companies file various forms with regulators
FX | Jul 29, 2026, 10:24 AM UTC
H
Why Bloom Energy Shares Are Trading Higher By 11%; Here Are 20 Stocks Moving Premarket
Shares of Bloom Energy Corp (NYSE: BE ) rose sharply in pre-market trading after the company reported better-than-expected second-quarter financial results and raised its FY26 guidance above estimates. Bloom Energy poste
EARNINGS | Jul 29, 2026, 08:57 AM UTC
M
AMIX: Trading Halt
AMIX trading halt status updated at 8:55:00 AM ET with quotation resumption news and times
EQUITY | Jun 24, 2026, 12:57 PM UTC
L
DD, AMIX Split
Stock Splits for Wednesday June 24 DD 1-for-3 reverse AMIX 1-for-21 reverse
EQUITY | Jun 24, 2026, 09:06 AM UTC
L
DD, AMIX Split
DD and AMIX undergo reverse stock splits
EQUITY | Jun 23, 2026, 07:16 PM UTC
M
AMIX Launches Neural Sensing Program
Autonomix Medical announces standalone neural sensing program with evidence of real-time renal nerve activity change
EQUITY | Jun 22, 2026, 12:01 PM UTC
M
AMIX Announces Reverse Split
Autonomix announces a reverse stock split
EQUITY | Jun 18, 2026, 08:30 PM UTC